Donor apoptotic cell–based therapy for effective inhibition of donor-specific memory T and B cells to promote long-term allograft survival in allosensitized recipients
Open Access
- 10 April 2020
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 20 (10), 2728-2739
- https://doi.org/10.1111/ajt.15878
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P01 AI112522, R01 EB009910)
- Northwestern University (T32)
This publication has 59 references indexed in Scilit:
- Ethylenecarbodiimide-Fixed Donor Splenocyte Infusions Differentially Target Direct and Indirect Pathways of Allorecognition for Induction of Transplant ToleranceThe Journal of Immunology, 2012
- Anti-CD45RB/Anti-TIM-1-Induced Tolerance Requires Regulatory B CellsAmerican Journal of Transplantation, 2012
- Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in miceJCI Insight, 2011
- Cutting Edge: Hierarchy of Maturity of Murine Memory B Cell SubsetsThe Journal of Immunology, 2010
- B Cells Help Alloreactive T Cells Differentiate Into Memory T CellsAmerican Journal of Transplantation, 2010
- Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney TransplantationJournal of the American Society of Nephrology, 2010
- Memory T-cell-specific therapeutics in organ transplantationCurrent Opinion in Organ Transplantation, 2009
- Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic PatientsDiabetes, 2009
- Biochemical signaling pathways for memory T cell recallSeminars in Immunology, 2009
- ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanismsProceedings of the National Academy of Sciences of the United States of America, 2008